← Back to trade feed
SYK Sell (partial)
Thomas KeanRepublican · NJ-7 · HouseTraded Jul 22, 2026Notified Aug 7, 2026
Trade details
| Amount | $1,001 – $15,000 |
| Asset | Stryker Corporation Common Stock (SYK) [ST] (ST) |
| Issuer | STRYKER CORP |
| Disclosure | 2026 PTR |
What happened next
Stock performance after the trade and after the disclosure became public, compared with SPY, an S&P 500 ETF.
Historical market data is not connected yet.
Conflict Score
65
Direct jurisdiction
Committee–industry overlap. The explanation and original filing are available below.
Why this score
- Rep. Thomas Kean (R-NJ) sits on the HSIF, whose jurisdiction covers: health.
- STRYKER CORP (SIC 3841: Surgical & Medical Instruments & Apparatus) maps to the health domain, placing it under that committee's direct oversight.
Powered by the base rules engine. Modifiers (trade size, timing, owner, options) are layered in a later release.
What do the scores mean? Committee–industry overlap
- 65
- Direct jurisdiction
- 50
- Subcommittee
- 30
- Sector overlap
- 18
- Broad jurisdiction
- 0
- No mapped overlap
- —
- Not scored · missing data
The current base model tops out at 65 on a reserved 0–100 scale. Scores are not probabilities or findings of wrongdoing. Zero means no overlap in our mapping, not an absence of all possible conflicts. Read the methodology →
Original extracted asset text
Stryker Corporation Common Stock (SYK) [ST]
Extraction may include form headers. The linked original filing is authoritative.